Oragenics, Inc. Gains 33.33%
Fri, May 10, 2024 at 10:52 PM
Oragenics, Inc. (OGEN:NYSEMKT) rocketted at $1.84, representing a gain of 33.3%. On Fri, May 10, 2024, OGEN:NYSEMKT touched a New 2-Week High of $1.84. The stock appeared on our News Catalysts scanner on Tue, May 07, 2024 at 10:22 AM in the 'PATNERSHIP' category. From Mon, Apr 29, 2024, the stock recorded 77.78% Up Days and 60.00% Green Days
About Oragenics, Inc. (OGEN:NYSEMKT)
Oragenics Inc is a biopharmaceutical company which engages in the discovery, development and commercialization of technologies associated with oral health, broad spectrum antibiotics and other general health benefits.
Top 10 Gainers:
- AEye Inc. (LIDR:NASDAQ), 118.64%
- Novavax, Inc. (NVAX:NASDAQ), 98.66%
- Power REIT (PW:NYSEMKT), 57.59%
- iTeos Therapeutics Inc. (ITOS:NASDAQ), 43.07%
- Sensus Healthcare, Inc. (SRTS:NASDAQ), 38.85%
- CareDx, Inc (CDNA:NASDAQ), 34.09%
- Sweetgreen Inc. Class A (SG:NYSE), 33.96%
- Oragenics, Inc. (OGEN:NYSEMKT), 33.33%
- Organogenesis Holdings Inc. (ORGO:NASDAQ), 32.89%
- Inseego Corp. (INSG:NASDAQ), 30.99%